These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16234961)

  • 1. Long-term effect of strontium ranelate treatment on BMD.
    Blake GM; Fogelman I
    J Bone Miner Res; 2005 Nov; 20(11):1901-4. PubMed ID: 16234961
    [No Abstract]   [Full Text] [Related]  

  • 2. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 3. [Strontium Ranelate as a new therapeutic agent for osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2005 Jan; 15(1):25-8. PubMed ID: 15632469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY; Bruyère O; Sawicki A; Roces-Varela A; Fardellone P; Roberts A; Devogelaer JP
    Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium ranelate improves bone microarchitecture in osteoporosis.
    Hamdy NA
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.
    Boonen S
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S21-7. PubMed ID: 16735842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium ranelate: a look back at its use for osteoporosis.
    Reginster JY; Neuprez A
    Expert Opin Pharmacother; 2010 Dec; 11(17):2915-27. PubMed ID: 21050035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
    Rolland Y; Abellan Van Kan G; Gillette-Guyonnet S; Roux C; Boonen S; Vellas B
    Bone; 2011 Feb; 48(2):332-8. PubMed ID: 20817053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM
    Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: "Effect of long-term treatment with strontium ranelate on bone strontium content" by Bärenholdt et al. (Bone, 2009).
    Belissa-Chatelain P; Dupin-Roger I; Cournarie F; Tsouderos Y
    Bone; 2009 Nov; 45(5):1024-5; author reply 1026-7. PubMed ID: 19616656
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
    Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
    J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.
    Marie PJ
    Mol Interv; 2010 Oct; 10(5):305-12. PubMed ID: 21045244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium as therapy for osteoporosis.
    Marie PJ
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
    Middleton ET; Steel SA; Aye M; Doherty SM
    J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
    Marie PJ
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strontium ranelate].
    Masaki H; Miki T
    Clin Calcium; 2006 Jan; 16(1):137-44. PubMed ID: 16397364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S
    J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium ranelate in osteoporosis.
    Reginster JY
    Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of strontium ranelate, raloxifene and misoprostol on bone mineral density in ovariectomized rats.
    Ahmet-Camcioglu N; Okman-Kilic T; Durmus-Altun G; Ekuklu G; Kucuk M
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):192-4. PubMed ID: 19796864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S; Vai S
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.